Shares

9 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Jul 19, 2022

SELL
$62.69 - $88.44 $564 - $795
-9 Closed
0 $0
Q1 2022

May 03, 2022

BUY
$63.15 - $90.42 $568 - $813
9 New
9 $1,000
Q4 2019

Jan 23, 2020

SELL
$76.53 - $135.58 $6,351 - $11,253
-83 Closed
0 $0
Q3 2019

Nov 06, 2019

SELL
$72.81 - $156.91 $50,967 - $109,837
-700 Reduced 89.4%
83 $6,000
Q2 2019

Jul 22, 2019

BUY
$112.21 - $151.95 $77,985 - $105,605
695 Added 789.77%
783 $119,000
Q1 2019

Apr 18, 2019

SELL
$106.67 - $151.68 $200,966 - $285,765
-1,884 Reduced 95.54%
88 $10,000
Q4 2018

Jan 29, 2019

BUY
$97.32 - $148.76 $101,407 - $155,007
1,042 Added 112.04%
1,972 $215,000
Q3 2018

Oct 29, 2018

BUY
$115.31 - $161.51 $20,755 - $29,071
180 Added 24.0%
930 $147,000
Q2 2018

Jul 30, 2018

BUY
$71.74 - $153.69 $53,804 - $115,267
750 New
750 $99,000

Others Institutions Holding SRPT

About Sarepta Therapeutics, Inc.


  • Ticker SRPT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 87,567,904
  • Market Cap $10.9B
  • Description
  • Sarepta Therapeutics, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery and development of RNA-targeted therapeutics, gene therapies, and other genetic therapeutic modalities for the treatment of rare diseases. It offers EXONDYS 51 injection to treat duchenne muscular dystrophy (duchenne) in patients with confirmed mut...
More about SRPT
Track This Portfolio

Track Harel Insurance Investments & Financial Services Ltd. Portfolio

Follow Harel Insurance Investments & Financial Services Ltd. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Harel Insurance Investments & Financial Services Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Harel Insurance Investments & Financial Services Ltd. with notifications on news.